» Articles » PMID: 37505679

Cyanotoxins Increase Cytotoxicity and Promote Nonalcoholic Fatty Liver Disease Progression by Enhancing Cell Steatosis

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2023 Jul 28
PMID 37505679
Authors
Affiliations
Soon will be listed here.
Abstract

Freshwater prokaryotic cyanobacteria within harmful algal blooms produce cyanotoxins which are considered major pollutants in the aquatic system. Direct exposure to cyanotoxins through inhalation, skin contact, or ingestion of contaminated drinking water can target the liver and may cause hepatotoxicity. In the current study, we investigated the effect of low concentrations of cyanotoxins on cytotoxicity, inflammation, modulation of unfolded protein response (UPR), steatosis, and fibrosis signaling in human hepatocytes and liver cell models. Exposure to low concentrations of microcystin-LR (MC-LR), microcystin-RR (MC-RR), nodularin (NOD), and cylindrospermopsin (CYN) in human bipotent progenitor cell line HepaRG and hepatocellular carcinoma (HCC) cell lines HepG2 and SK-Hep1 resulted in increased cell toxicity. MC-LR, NOD, and CYN differentially regulated inflammatory signaling, activated UPR signaling and lipogenic gene expression, and induced cellular steatosis and fibrotic signaling in HCC cells. MC-LR, NOD, and CYN also regulated AKT/mTOR signaling and inhibited autophagy. Chronic exposure to MC-LR, NOD, and CYN upregulated the expression of lipogenic and fibrosis biomarkers. Moreover, RNA sequencing (RNA seq) data suggested that exposure of human hepatocytes, HepaRG, and HCC HepG2 cells to MC-LR and CYN modulated expression levels of several genes that regulate non-alcoholic fatty liver disease (NAFLD). Our data suggest that low concentrations of cyanotoxins can cause hepatotoxicity and cell steatosis and promote NAFLD progression.

Citing Articles

Nodularin-R Synergistically Enhances Abiraterone Against Castrate- Resistant Prostate Cancer via PPP1CA Inhibition.

Huang Y, Cen Y, Wu H, Zeng G, Su Z, Zhang Z J Cell Mol Med. 2024; 28(22):e70210.

PMID: 39550701 PMC: 11569623. DOI: 10.1111/jcmm.70210.


Cyanotoxin Occurrence and Diversity in 98 Cyanobacterial Blooms from Swedish Lakes and the Baltic Sea.

Dirks C, Cappelli P, Blomqvist M, Ekroth S, Johansson M, Persson M Mar Drugs. 2024; 22(5).

PMID: 38786590 PMC: 11123207. DOI: 10.3390/md22050199.

References
1.
Mackintosh C, Beattie K, Klumpp S, Cohen P, Codd G . Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett. 1990; 264(2):187-92. DOI: 10.1016/0014-5793(90)80245-e. View

2.
Hercog K, Stampar M, Stern A, Filipic M, Zegura B . Application of advanced HepG2 3D cell model for studying genotoxic activity of cyanobacterial toxin cylindrospermopsin. Environ Pollut. 2020; 265(Pt B):114965. DOI: 10.1016/j.envpol.2020.114965. View

3.
Ma J, Li Y, Duan H, Sivakumar R, Li X . Chronic exposure of nanomolar MC-LR caused oxidative stress and inflammatory responses in HepG2 cells. Chemosphere. 2017; 192:305-317. DOI: 10.1016/j.chemosphere.2017.10.158. View

4.
Arman T, Baron J, Lynch K, White L, Aldan J, Clarke J . MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period. Toxicology. 2021; 464:153021. PMC: 8629135. DOI: 10.1016/j.tox.2021.153021. View

5.
Li Q, Lu C, Li W, Huang Y, Chen L . The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease. Oncotarget. 2017; 8(17):28641-28649. PMC: 5438679. DOI: 10.18632/oncotarget.16162. View